Overview Financials News + Filings Key Docs Charts Ownership Insiders |
TECOGEN INC. (TGEN)
|
Add to portfolio |
|
|
Price: |
$1.75
| | Metrics |
OS: |
24.9
|
M
| |
-23
|
% ROE
|
Market cap: |
$43.5
|
M
| |
-32
|
% ROIC
|
Net cash:
|
$1.87
|
M
| |
$0.08
|
per share
|
EV:
|
$41.6
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($3.3)
|
M
| |
|
|
EBIT
|
($3.8)
|
M
| |
|
|
EPS |
($0.16)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 25.0 | 24.4 | 28.3 | 33.4 | 35.9 | 33.2 | 24.5 | 21.4 |
Revenue growth | 2.5% | -13.6% | -15.5% | -6.8% | 8.1% | 35.6% | 14.2% | 10.9% |
Cost of goods sold | 13.9 | 12.8 | 17.4 | 20.9 | 22.3 | 20.2 | 15.2 | 13.8 |
Gross profit | 11.1 | 11.6 | 10.8 | 12.5 | 13.6 | 13.0 | 9.3 | 7.6 |
Gross margin | 44.3% | 47.5% | 38.3% | 37.3% | 37.9% | 39.0% | 38.0% | 35.6% |
Sales and marketing | 1.8 | 2.5 | 2.6 | 2.7 | 2.7 | 2.3 | 1.6 | 1.7 |
Research and development | 0.7 | 0.5 | 0.8 | 1.5 | 1.3 | 0.9 | 0.7 | 0.6 |
General and administrative | 10.9 | 9.8 | 10.3 | 10.4 | 10.8 | 9.5 | 8.0 | 8.0 |
EBITA | -2.1 | -1.0 | -2.7 | -0.9 | -1.0 | 0.3 | -0.9 | -2.5 |
EBITA margin | -8.6% | -4.2% | -9.6% | -2.6% | -2.9% | 1.0% | -3.7% | -11.9% |
Amortization of intangibles | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
EBIT | -2.3 | -1.2 | -2.8 | -1.0 | -1.1 | 0.2 | -1.0 | -2.6 |
EBIT margin | -9.4% | -5.0% | -10.0% | -2.9% | -3.2% | 0.7% | -4.1% | -12.3% |
Pre-tax income | -2.4 | 3.8 | -6.2 | -4.8 | -5.8 | 0.1 | -1.2 | -2.8 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 |
Tax rate | | 0.5% | | | | 0.0% | 0.0% | 2.6% |
Net income | -2.4 | 3.7 | -6.2 | -4.7 | -5.7 | 0.0 | -1.1 | -2.7 |
Net margin | -9.8% | 15.1% | -21.8% | -14.1% | -15.9% | 0.1% | -4.5% | -12.7% |
|
Diluted EPS | ($0.10) | $0.15 | ($0.25) | ($0.19) | ($0.23) | $0.00 | ($0.06) | ($0.16) |
Shares outstanding (diluted) | 24.9 | 25.1 | 24.9 | 24.8 | 24.8 | 23.3 | 19.3 | 16.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|